The New NHAS
The new NHAS details opportunities, policy considerations,
recommended actions, and indicators.
This is reason enough to read the document carefully.
It provides a roadmap that the federal government
will use to measure progress.
The first thing I noticed was that all of the
changes I discussed above, and others that I don’t
yet clearly understand, have been integrated into
the new strategy in an interwoven manner. For
instance, it is clear that the money must go to where
the epidemic creates the most problems; data will
drive programming (and, therefore, funding). What
that translates to is more funding to research, prevention,
and treatment programs targeted to young
Black MSM and people who live in the U.S. Southeast.
Funding preferences should also be expected
for programs that integrate violence prevention
and trauma care, prevent HIV transmission, link infected
people into care, and retain them in care. New
drugs are important, but they alone are not the
answer. We know that many people living with or
at risk for HIV do not benefit from prevention and
medication advances, as is clearly shown in continuum
of care data (Figure 1).
The New NHASThe new NHAS details opportunities, policy considerations,recommended actions, and indicators.This is reason enough to read the document carefully.It provides a roadmap that the federal governmentwill use to measure progress.The first thing I noticed was that all of thechanges I discussed above, and others that I don’tyet clearly understand, have been integrated intothe new strategy in an interwoven manner. Forinstance, it is clear that the money must go to wherethe epidemic creates the most problems; data willdrive programming (and, therefore, funding). Whatthat translates to is more funding to research, prevention,and treatment programs targeted to youngBlack MSM and people who live in the U.S. Southeast.Funding preferences should also be expectedfor programs that integrate violence preventionand trauma care, prevent HIV transmission, link infectedpeople into care, and retain them in care. Newdrugs are important, but they alone are not theanswer. We know that many people living with orat risk for HIV do not benefit from prevention andmedication advances, as is clearly shown in continuumof care data (Figure 1).
การแปล กรุณารอสักครู่..
